breseq  version 0.35.4  revision f352f80f4bc9
mutation predictions | marginal predictions | summary statistics | genome diff | command line log

Marginal read alignment evidence
  seq id position ref new freq score (cons/poly) reads annotation genes product
*NC_000913_3_pae_pgi4,037,2250A.44.4% 4.9 / 11.8 10intergenic (+8/‑35)ileT/alaTtRNA‑Ile/tRNA‑Ala
*NC_000913_3_pae_pgi4,037,2271.T40.0% 0.5 / 15.6 10intergenic (+10/‑33)ileT/alaTtRNA‑Ile/tRNA‑Ala
*NC_000913_3_pae_pgi3,428,6780AT36.8% 13.5 / 20.0 19noncoding (85/1542 nt)rrsD16S ribosomal RNA of rrnD operon
*NC_000913_3_pae_pgi3,428,6790AT36.8% 13.5 / 20.0 19noncoding (84/1542 nt)rrsD16S ribosomal RNA of rrnD operon
*NC_000913_3_pae_pgi4,295,3200CT29.3% 377.1 / 192.9 246intergenic (+266/+376)gltP/yjcOglutamate/aspartate:proton symporter/Sel1 family TPR‑like repeat protein
*NC_000913_3_pae_pgi526,7960CG28.4% 320.2 / 156.7 169A1179G (GCG→GGG) rhsDRhs protein with DUF4329 family putative toxin domain; putative neighboring cell growth inhibitor
*NC_000913_3_pae_pgi526,7920AC28.3% 248.4 / 154.3 173S1178R (AGC→CGC) rhsDRhs protein with DUF4329 family putative toxin domain; putative neighboring cell growth inhibitor
*NC_000913_3_pae_pgi526,8000AG27.4% 286.6 / 111.9 164E1180E (GAA→GAGrhsDRhs protein with DUF4329 family putative toxin domain; putative neighboring cell growth inhibitor
*NC_000913_3_pae_pgi3,959,5150TA20.5% 286.8 / 72.3 117intergenic (+70/+17)ilvC/ppiCketol‑acid reductoisomerase, NAD(P)‑binding/peptidyl‑prolyl cis‑trans isomerase C (rotamase C)
*NC_000913_3_pae_pgi1,864,7580GA20.1% 392.2 / 96.1 184intergenic (+24/+24)yeaD/yeaED‑hexose‑6‑phosphate epimerase‑like protein/aldo‑keto reductase, methylglyoxal to acetol, NADPH‑dependent
*NC_000913_3_pae_pgi3,941,8920TA20.0% 46.8 / 10.1 25noncoding (85/1542 nt)rrsC16S ribosomal RNA of rrnC operon

Marginal new junction evidence (lowest skew 10 of 999 shown)
  seq id position reads (cov) reads (cov) score skew freq annotation gene product
* ? NC_000913_3_pae_pgi = 2068406537 (3.180)102 (0.700) 67/216 1.9 17.0% pseudogene (14/159 nt) yoeH pseudogene, CP4‑44 putative prophage remnant;Phage or Prophage Related
?NC_000913_3_pae_pgi = 2068411 535 (3.690)pseudogene (9/159 nt) yoeH pseudogene, CP4‑44 putative prophage remnant;Phage or Prophage Related
* ? NC_000913_3_pae_pgi 2068389 =422 (2.500)86 (0.590) 54/216 3.5 16.4% pseudogene (31/159 nt) yoeH pseudogene, CP4‑44 putative prophage remnant;Phage or Prophage Related
?NC_000913_3_pae_pgi 2068430 = 516 (3.560)intergenic (‑11/‑205) yoeH/yoeA pseudogene, CP4‑44 putative prophage remnant;Phage or Prophage Related/CP4‑44 prophage; putative disrupted hemin or colicin receptor;Phage or Prophage Related; interrupted by IS2 and C‑terminal deletion
* ? NC_000913_3_pae_pgi 2090108 =803 (4.750)86 (0.570) 51/224 4.3 10.8% intergenic (+62/‑84) hisL/hisG his operon leader peptide/ATP phosphoribosyltransferase
?NC_000913_3_pae_pgi 2090141 = 702 (4.670)intergenic (+95/‑51) hisL/hisG his operon leader peptide/ATP phosphoribosyltransferase
* ? NC_000913_3_pae_pgi 1207790 =143 (0.850)32 (0.220) 32/220 8.2 22.2% coding (290/630 nt) stfP e14 prophage; uncharacterized protein
?NC_000913_3_pae_pgi 1209619 = 100 (0.680)pseudogene (1/501 nt) stfE pseudogene, e14 prophage; side tail fiber protein fragment family;Phage or Prophage Related
* ? NC_000913_3_pae_pgi = 2084199837 (4.950)49 (0.310) 31/234 9.2 6.0% intergenic (+16/+27) sbcB/yeeD exodeoxyribonuclease I; exonuclease I/putative TusA family sulfurtransferase
?NC_000913_3_pae_pgi = 2084205 759 (4.830)intergenic (+22/+21) sbcB/yeeD exodeoxyribonuclease I; exonuclease I/putative TusA family sulfurtransferase
* ? NC_000913_3_pae_pgi 1552249 =NA (NA)39 (0.250) 29/228 9.5 NA noncoding (1/97 nt) RIP121 (repetitive extragenic palindromic) element; contains 2 REP sequences and 1 IHF site RIP121 (repetitive extragenic palindromic) element; contains 2 REP sequences and 1 IHF site
?NC_000913_3_pae_pgi 1552279 = NA (NA)noncoding (31/97 nt) RIP121 (repetitive extragenic palindromic) element; contains 2 REP sequences and 1 IHF site RIP121 (repetitive extragenic palindromic) element; contains 2 REP sequences and 1 IHF site
* ? NC_000913_3_pae_pgi 1552071 =NA (NA)38 (0.250) 28/228 9.8 NA noncoding (1/97 nt) RIP120 (repetitive extragenic palindromic) element; contains 2 REP sequences and 1 IHF site RIP120 (repetitive extragenic palindromic) element; contains 2 REP sequences and 1 IHF site
?NC_000913_3_pae_pgi 1552279 = NA (NA)noncoding (31/97 nt) RIP121 (repetitive extragenic palindromic) element; contains 2 REP sequences and 1 IHF site RIP121 (repetitive extragenic palindromic) element; contains 2 REP sequences and 1 IHF site
* ? NC_000913_3_pae_pgi = 2098422625 (3.700)44 (0.280) 29/236 9.9 7.0% intergenic (‑121/+25) wzzB/ugd regulator of length of O‑antigen component of lipopolysaccharide chains/UDP‑glucose 6‑dehydrogenase
?NC_000913_3_pae_pgi = 2098429 579 (3.660)intergenic (‑128/+18) wzzB/ugd regulator of length of O‑antigen component of lipopolysaccharide chains/UDP‑glucose 6‑dehydrogenase
* ? NC_000913_3_pae_pgi 2097275 =NA (NA)34 (0.210) 30/242 9.9 5.4% intergenic (+50/+46) hisI/wzzB phosphoribosyl‑AMP cyclohydrolase and phosphoribosyl‑ATP pyrophosphatase/regulator of length of O‑antigen component of lipopolysaccharide chains
?NC_000913_3_pae_pgi 2097299 = 593 (3.650)intergenic (+74/+22) hisI/wzzB phosphoribosyl‑AMP cyclohydrolase and phosphoribosyl‑ATP pyrophosphatase/regulator of length of O‑antigen component of lipopolysaccharide chains
* ? NC_000913_3_pae_pgi 2075078 =585 (3.460)40 (0.250) 28/236 10.2 6.6% coding (300/1533 nt) yeeR CP4‑44 prophage; putative membrane protein
?NC_000913_3_pae_pgi 2075101 = 576 (3.640)coding (323/1533 nt) yeeR CP4‑44 prophage; putative membrane protein